Pharmacogenomics: The Search for Individualized Therapies

Introduction to Pharmacogenomics: Promises, Opportunities & Limitations The Human Genome Turning SNPs into Useful Markers of Durg Response Association studies in Pharmacogenomics Genomics Applications that Facilitate the Undrstanding of Durg Action & Toxicity The Role of Pharmacogentics in Drug Discovery & Therapeutics Pharnacogenomics & Drug Design Pharmacogenomics of Human P-Glycoprotein Phramacogenomics of Durg Transporters Pharmacogenomics of Asthma Treatment Endothelial Cell are Targets for Hydroxy Urea: Relevance to the current Therapeutic Strategy in Sickle Cell Disease Pharmacogenomics & Complex Cardiovascular diseases Clinical Studies in Candidate Genes Pharmacogenomics of Lipid-Lowering Agents Pharmacogenomics of Chemotherapeutics Agent in Cancer Treatment Pharmacogenomics of the Blood-Brain Barrier Pharmacogenomics & the Treatment of Neurological Disease Pharmacogenomics of Neurodegenerative Diseases: Examples & Perspectives Psychiatric Pharmacogentics: Prediction of Treatment Outcomes in Schizophrenia Pharmacogenomics of Major Depression & Antidepressant Treatment Pharmacogenomics of Bipolar Disorder Pharmacogenomics of Alcoholism Pharmacogenomics of Tobacco Addiction Pharmacogenomics of Opioid Systems Ethnicity & Pharmacogenomics Pharmacogenomics: Ensuring Equity Regarding Durgs Based on Genetic Differnece Translation of Vasscular Proteomic into Individualized Therapeutics Glossary of key term in Molecular Genetics of Pharmacogenomics